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Abstract 
Background and Purpose. The mesolimbic dopamine (DA) system originating in the ventral 
tegmental area (VTA) is implicated in the development of depression, and firing patterns of 
VTA DA neurons are key determinants in this process. Here, we describe a crucial role of the 
M-type potassium channel Kv7.4 in modulation of VTA DA neuronal excitability and in the 
development of depressive behaviour in mice.  
Experimental Approach. We used Kv7.4 knock-out mice and a social defeat model of 
depression in combination with various electrophysiological techniques (patch clamp 
recording and in vivo single unit recordings), immunohistochemistry, single-cell PCR and 
behavioural analyses (social interaction time and glucose preference tests) to investigate VTA 
circuits involved in development of depression-like behaviour. 
Key results. We demonstrate that among the Kv7 channel subunits, Kv7.4 is selectively 
expressed in dopamine neurons of the VTA. Using a newly identified selective Kv7.4 
activator fasudil and Kv7.4 knock-out mice, we demonstrate that Kv7.4 is a dominant 
modulator of VTA DA neuronal excitability in vitro and in vivo. The results also demonstrate 
that down-regulation of Kv7.4 could be a causal factor of the altered excitability of VTA DA 
neurons and depression-like behaviour. Finally, the selective Kv7.4 activator fasudil strongly 
alleviated depression-like behaviour in the social defeat mouse model of depression.  
Conclusion and Implications. Because expression of Kv7.4 in the CNS is limited, 
selectively targeting this M channel subunit is likely to produce less on-target side effects 
than non-selective M channel modulators, and thus, Kv7.4 may offer an alternative target for 
treating depression. 
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Abbreviations 
DA Dopamine  
ISI Inter-spike interval 
RTG Retigabine 
SK channels Small conductance Ca2+-activated K+ channels 
SN Substantia nigra 
SUS mice Susceptible mice 
TH Tyrosine hydrolase 
UNSUS mice Unsusceptible mice 
VTA Ventral tegmental area 
 
Introduction 
Current treatments available for major depression are unsatisfactory due to their multiple side 
effects and low efficacy, leaving more than one-third of depressed individuals resistant to 
drug treatments (Wong and Licinio, 2001). In addition, antidepressants usually take several 
weeks to months to produce a therapeutic response. Thus, new strategies are needed to 
understand the pathophysiology of major depression and to develop new therapeutic 
treatments. Growing evidence has implicated the mesolimbic dopamine (DA) system 
originating in the ventral tegmental area (VTA) in the pathogenesis and treatment of 
depression (Dunlop and Nemeroff, 2007; Gershon et al., 2007; Krishnan et al., 2007). VTA 
DA neurons fire either WRQLFDOO\RULQµSKDVLF¶EXUVWV, and these firing patterns were shown to 
encode different types of behaviour (Schultz, 2007). The phasic burst firing of VTA DA 
neurons is sufficient to drive behavioural conditioning and elicit dopamine transients with 
magnitudes not achieved by longer, lower-frequency spiking (Tsai et al., 2009). More 
importantly, it has been recently demonstrated that the phasic burst firing pattern of VTA DA 
neurons directly controls depression-like behaviour in rodent models of depression 
(Chaudhury et al., 2013; Tye et al., 2013). 
A key to understanding the molecular and cellular mechanisms underlying depression lies in 
deciphering the firing patterns of VTA DA neurons and identification of the main molecular 
players controlling such patterns (Grace et al., 2007). Ionotropic NMDA receptors and 
  
Ca2+-activated K+ (SK) channels (Creed et al., 2016), HCN (Cao et al., 2010; Neuhoff et al., 
2002) and Kir3/GIRK channels (Munoz and Slesinger, 2004; Padgett et al., 2012) have all 
been suggested to play important roles in controlling either the intrinsic DA neuronal activity 
or the abusive drug-induced modulation of such activity. However, despite significant 
progress, a complete understanding of the firing patterns within the VTA circuitry and what 
controls these patterns is currently lacking. One emerging concept for treating depression is 
focused on modulation of VTA DA neuron K+ channels (Borsotto et al., 2015; Overstreet and 
Wegener, 2013). This concept is based on several experimental findings suggesting that K+ 
channels controlling VTA DA neuron excitability may be targeted to reduce the neuronal 
firing and the susceptibility of mice to social depression stress (Friedman et al., 2014; 
Krishnan et al., 2007; Friedman et al., 2016). Several other studies implicated K+ channels in 
depression (even though some of these observations are not directly compatible), thus, 
genetic deletion of TREK1 K+ channels produces an intrinsic antidepressant-like phenotype, 
which is not affected by further SSRI antidepressants treatments (Heurteaux et al., 2006), 
while selective blockade of TREK1 with spadin or its analogues exerts a fast anti-depressant 
effect (Mazella et al., 2010; Veyssiere et al., 2015).  
One family of K+ channels, which is increasingly recognized for their role in controlling 
neuronal firing, is Kv7/KCNQ family. Kv7/KCNQ channels (Kv7.1-5) are voltage-dependent 
potassium channels with five members, four of which (Kv7.2±5) are abundantly expressed in 
the CNS (Wang et al., 1998; Jentsch, 2000; Gamper and Shapiro, 2015). Kv7 channels 
opening leads to neuronal hyperpolarization, membrane potential stabilization and decreased 
excitability. This makes Kv7 channels particularly interesting as targets in neurological 
disorders linked to hyperexcitability, including epilepsy, anxiety, pain, migraine and 
addiction to psychostimulants (Brown and Passmore, 2009). Interestingly, Kv7 channels are 
expressed in DA neurons (Hansen et al., 2006; Koyama and Appel, 2006) and have been 
suggested to modulate DA neuronal excitability (Drion et al., 2010; Hansen et al., 2008) and 
dopaminergic transmission (Hansen et al., 2008). On the transcriptional level, Kv7.4 was 
found to be a predominant KCNQ gene expressed in VTA DA (Hansen et al., 2006), although 
the functional expression and potential role of Kv7 channels in depression have not been 
elucidated. In this study, we provide strong evidence that Kv7.4 is a dominant Kv7 subunit in 
  
the VTA and a potent modulator of VTA DA neuronal excitability. Due to the much more 
restricted expression of Kv7.4 in the CNS compared to other Kv7 subunits, targeting this 
channel may offer a new way to treat depression, and such a strategy could be less prone to 
on-target side effects than current treatments. 
Materials and Methods 
Animals  
Kv7.4 knock-out mice (Kv7.4-/-) were kindly provided by Prof Thomas Jentsch (FMP, MDC, 
Berlin, Germany) (Tatjana Kharkovets, 2006). A total of 321 male wild-type and 210 male 
Kv7.4-/- C57BL/6J mice (7-8 weeks old,Vital River, China) were used for the studies. All 
animals were housed at controlled temperature, humidity and lighting (12 h: 12 h light-dark 
cycle) and provided free access to food (provided by Experimental Animal Center of Hebei 
Province) and tapwater ad libitum. Animals were allowed to adapt to their housing 
environment for at least 7 days prior to experimentation and to the experimental room for 1 
day before experiments. Animal studies were conducted in compliance with the ARRIVE 
guidelines (Kilkenny et al., 2011; Mcgrath and Lilley, 2015). All experiments were 
conducted in accordance with the guides of the Animal Care and Use Committee at Hebei 
Medical University. The use of human tissue was approved by the Ethnic Committee of 
Hebei Medical University. 
 
Cell culture  
Chinese hamster ovary (CHO) K1 cells stably expressing Kv7.4 or Kv7.2/7.3 channels were 
maintained in F12 media (Life Technologies, USA) supplemented with 10% foetal calf serum, 
non-essential amino acid supplement (Gibco, USA), 600(?ȝJ·ml-1 G418 and 600(?ȝJ ml-1 
hygromycin B and incubated at 37°C in 5% CO2. CHO K1 cells transiently transfected with 
Kv7.2 were grown in F12 supplemented with 10% foetal calf serum and 1% 
penicillin-streptomycin. Cells were grown on glass coverslips and transfected using 
Lipofectamine (Life Technologies, USA). Recordings were performed 24-48 h after 
transfection. Human Kv7.2, rat Kv7.3, and human Kv7.4 (GenBank accession numbers: 
AF110020, AF091247, AF105202, respectively) were kindly provided by Diomedes E. 
Logothetis (Virginia Commonwealth University, Richmond, Virginia, USA) and were 
  
subcloned into pcDNA3. 
 
VTA brain slice preparation 
Brain slices containing VTA/SN were prepared as reported (Krishnan et al., 2007). Mice were 
euthanized by pentobarbital sodium (200 mg kg-1, i.p) and brains were cut in a coronal plane, 
and sectioned into 250-ȝP-thick slices containing VTA/SN using a vibratome (VT1200S; 
Leica, Germany). The VTA was located stereotaxically, as described (Franklin and Paxinos, 
2001), as the region dorsal to the medial mammillary nucleus or the interpeduncular nucleus, 
medial to the substantia nigra and ventral to the red nucleus (Shabat-Simon et al., 2008). The 
coronal slices (250 ȝP ZHUH SUHSDUHG LQ LFH-cold oxygenated (95% O2/5% CO2) cutting 
solution (in mM: KCl 2.5, NaH2PO4 1.25, NaHCO3 25, CaCl2 0.5, MgCl2 7, D-glucose 10 and 
sucrose 220; osmolarity, 295-305 mOsm) and incubated for 30 min at 36°C in oxygenated 
artificial cerebrospinal fluid (aCSF) (in mM: NaCl 124, KCl 3, NaH2PO4 1.24, MgCl2 2, 
CaCl2 2, D-glucose 10 and NaHCO3 26; osmolarity, 280-300 mOsm). Four coronal slices 
(250 µm) containing the VTA/SN were obtained from each mouse. The slices were allowed 
to recovery at room temperature (23-25°C) in oxygenated aCSF for at least 1 h prior to 
recording. Recording were made at room temperature in a recording chamber continuously 
perfused with oxygenated aCSF (2 ml min-1). 
The human brainstem from a 45-year-old male who died of sudden cardiac death without 
neuropsychiatric, neurological, or neurodegenerative disease was obtained from the 
Department of Forensic pathology of Hebei Medical University. The use of a human tissue 
sample was approved by the Ethnic Committee For Human Tissue Samples.  
 
VTA DA neuron identification 
DA neurons were distinguished from non-DA neurons either by the presence of tyrosine 
hydroxylase (TH; single-cell PCR) or based on the functional characteristics of DA neurons 
as follows: i) A sag hyperpolarization potential during injection of a hyperpolarizing current 
pulse (sFig. 1A, 1B); ii) a typical triphasic action potential with a negative deflection, an 
action potential width from the start to the minimum of > 1.1 ms, and an action potential 
duration (from start to recovery at resting membrane rest) > 2.5 ms (sFig. 1C, 1D); iii) firing 
  
rate less than 5 Hz (in loose patch or single unit recordings where spontaneous firing was 
recorded; see below); and iv) inhibition of the firing activity by dopamine (Cao et al., 2010; 
Ungless et al., 2004). 
 
Electrophysiology 
Kv7 current recordings in CHO cells expressing Kv7 were performed using the perforated 
patch configuration of the patch-FODPSWHFKQLTXHDPSKRWHULFLQ%ȝJ·ml-1, Sigma, USA) 
at room temperature using a HEKA EPC10 patch-clamp amplifier and Patch Master software 
(HEKA Electronics, Germany). Currents were acquired at 10 kHz and filtered at 2.5 kHz. 
Patch electrodes were pulled with a micropipette puller (Sutter Instruments, USA) and 
polished to 2-4 Mȍresistance. The intracellular solution contained (in mM): KCl 150, MgCl2 
5, HEPES 10, pH adjusted to 7.4 ZLWK.2+6HULHVUHVLVWDQFHJHQHUDOO\EHORZ0ȍZDV
compensated by 60-80%. The extracellular solution contained (in mM): NaCl 160, KCl 2.5, 
MgCl2 1, CaCl2 2, glucose 10, HEPES 20; pH adjusted to 7.4 with NaOH. Cells were held at 
a holding potential of -60 mV, and 1-s test pulses to -10 mV were applied every 6 s.   
For whole-cell current-clamp and voltage-clamp recordings in the VTA slices, an Axopatch 
1D amplifier coupled with a Digidata 1440A AD converter (Molecular Devices, USA) was 
used, and the data were analysed using Clampex 10.3 (Molecular Device, USA) and 
OriginPro 8.5 software (Origin Lab Corporation, USA). For Kv7/M current recordings, 
neurons were held at -10 mV and 1-s square pulses to -50 mV were delivered repeatedly at 
20-s intervals. The M current was measured as the instantaneous deactivating tail current at 
the beginning of a voltage step to -50 mV. Whole-cell patch-clamp recordings were made 
with glass electrodes (4- 0ȍ XVLQJ DQ LQWHUQDO VROXWLRQ FRQWDLQLQJ LQ P0
K-methylsulfate 115, KCl 20, MgCl2 1, HEPES 10, EGTA 0.1, MgATP 2 and Na2GTP 0.3, 
pH adjusted to 7.4 with KOH. The extracellular solution was the aCSF. A cell-attached 
³ORRVH-SDWFK´ -300 Mȍ) (Burlet et al., 2002) recordings were also used to record 
spontaneous firing of DA neurons. In this case, the pipette solution contained aCSF. 
Single unit recordings were used to record the spontaneous firing of VTA DA neurons in vivo 
based on a previously reported method (Mameli-Engvall et al., 2006). Briefly, mice were 
anaesthetized by 4% chloral hydrate (400 mg·kg-1, i.p.); the coordinates for the VTA were 
  
2.92-3.16 mm from the anterior fontanel, 0.50-0.70 mm lateral from the midline and 
4.20-5.00 mm ventral from the cortical surface. DA neurons were identified by their 
characteristics of the action potentials (typical triphasic action potentials with a negative 
deflection: the action potential width from the start to the minimum trough of   PV, a 
characteristic long duration (> 2 ms) and a slow firing rate (< 10 Hz) (Cao et al., 2010) (Fig. 
3F). The presence of burst firing (as opposed to tonic firing) was identified by the following 
criteria: 1) the start of a burst was registered when two consecutive spikes fired within 80 ms; 
2) the end of the burst was registered when the interspike interval (ISI) exceeded 160 ms 
(Cao et al., 2010); and 3) a neuron was considered as burst-firing if it fired at least one burst 
within 3 min. Electrical signals were amplified and filtered (10-4K Hz) by the Axoclamp 
900A preamplifier and recorder by the Digidata 1440A AD converter (Molecular Devices, 
USA); the data were analysed by Clampfit 10.3 (Molecular Devices, USA).  
The effect of 0.9% saline (vehicle), fasudil (20 mg·kg-1) or retigabine (RTG) (10 mg·kg-1) on 
the firing activity of VTA DA neurons recorded using single unit recordings was assessed 10 
min after intraperitoneal injection (i.p.) or 5 min after direct VTA local pressure (5 - 15 psi) 
injection (see Fig. 6 legend for detail). The effects of drugs on the following parameters were 
analysed: (i) average firing rates (Hz); ii) corresponding ISI (ISI histograms were plotted for 
at least 5 min of continuous recording); iii) percentage of cells displaying burst firing 
(number of burst firing cells/ number of all cells recorded × 100%); iv) average number of 
spikes in a burst (number of spikes in burst/ number of burst events); and v) percentage of 
spikes in bursts (number of spikes in bursts/total number of spikes × 100%).   
Chronic social defeat stress 
The mouse social defeat model of depression was established based on the protocols reported 
previously (Krishnan et al., 2007). Briefly, the C57BL/6 mice were subjected to attack by a 
CD1 mouse for 10 min a day for 10 days. CD1 retired breeders were selected before the test, 
and the fiercest CD1 mice were excluded in the following experiment. In addition, the 
intensity of attack stimuli was minimized to produce stable depressive behaviour. To 
minimize harm and avoid physical injury, plastic dividers were set when C57BL/6J mice 
displayed submissive behaviour, including immobility, crouching, trembling, fleeing and 
upright posture. On day 1 and day 11, the weight was recorded, and a sucrose preference test 
  
was performed as follows. Mice were individually accommodated in cages with two drinking 
water bottles for 24 h (food provided ad libitum). The animals were then deprived of water 
and food for 12 h. After this period, two drinking bottles were re-introduced with one 
containing 0.8% sucrose solution and the other filled with drinking water. Twelve hours later, 
the bottles were removed and weighted. Sucrose preference was calculated as a percentage 
[(weight of sucrose solution consumed / total weight of liquid consumed from two bottles) × 
100%]. On day 13, the social interaction test was carried out. The C57BL/6 mice were placed 
in an interaction test box and allowed to move freely for 2.5 min in the absence or presence 
of an unfamiliar caged CD1 mouse. The time the test C57BL/6 mice spent in the interaction 
zone and in the corner zone (see sFig. 2A, 2B) was analysedanalyse (sFig. 2C). Subgroups of 
susceptible and unsusceptible mice were identified. The animals were qualified as susceptible 
to depression-like behaviour (SUS) if they spent significantly less time in the interaction zone 
while a CD1 mouse was present than while a CD1 mouse was not present. Animals that did 
not respond to the presence of a CD1 mouse by reduced interaction time were qualified as 
unsusceptible mice (UNSUS). Sucrose preference was an additional test used to determine 
depression susceptibility (see below). Animals were divided into groups randomly. 
Experimenters were blinded to the drug treatment while performing the tests. 
 
Cannula implantation for direct injection of drugs into the VTA  
Mice were anaesthetized by intraperitoneal injection of 8% chloral hydrate (400 mg·kg-1, i.p) 
and placed into a stereotaxic apparatus. Mice were bilaterally implanted with a stainless 
26-gauge cannula fitted with obturators (Plastics One) targeting directly above the VTA with 
the following coordinates: anteroposterior, 3.08 mm; lateral, 0.50 mm; dorsoventral, 4.20 mm. 
The cannulae were secured with dental cement; and the mice were then singly housed and 
allowed to recover for 3 days. After the surgery, the mice were housed at 28Ԩ for 8 h to 
maintain their body temperature. All instruments were autoclaved, and the skin of the animals 
was sterilized with alcohol and iodine to prevent infection after surgery. The animals were 
placed in a cage with clean sawdust bedding and provided free access to fresh water and food 
(provided by Experimental Animal Center of Hebei Province). 
 
  
Western blotting  
Mice were euthanized by pentobarbital sodium (200 mg·kg-1, i.p) and perfused transcardially 
with 0.01 m ice-cold PBS. Brains were rapidly removed and VTA punches (2 mm diameter, 2 
mm thick) from these mice were sonicated in 1% SDS lysis buffer containing protease 
inhibitor and centrifuged at 4°C for 30 min at 17220 g. Protein samples (40 mg) were 
separated by 10% SDS-PAGE for 1.5 h and transferred to a nitrocellulose membrane for 2 h 
in 20% transfer buffer. Membranes were then blocked for 1 hour at room temperature in 
TBST (TBS and 0.1% Tween-20) with 5% nonfat milk (Sigma, USA) and then were 
incubated overnight at 4°C with primary antibody against Kv7.4 (1:1000, Alomone Labs, 
86$RUȕ-tubulin (1:10000, Abcam, UK) diluted in TBST. Membranes were washed with 
TBST for 3 × 10 min,  incubated with goat anti-rabbit (1:5000, Rockland, USA) or goat 
anti-mouse (1:7500, Rockland, USA) secondary antibodies for 1 h at room temperature, and 
washed with TBST for 2 × 10 min followed by another 10-min wash with TBS. Membranes 
were imaged using an Odyssey infrared imaging system (LI-COR, USA); the integrated 
optical density of each band was measured using ImageJ software (National Institutes of 
Health, USA). 
 
Immunofluorescence 
For experiments shown in Fig. 1D, mice were euthanized by pentobarbital sodium (200 
mg·kg-1, i.p) and perfused transcardially with 0.01 m ice-cold PBS, followed by ice-cold PBS 
containing 4% paraformaldehyde (PFA). The brain was removed, fixed in 4% PFA at 4°C for 
48 h and embedded in paraffin. Paraffin coronal VTA/SN slices (5 µm) were mounted on 
glass slides. Coronal VTA/SN slices located at 1.40 to 0.50 mm from lambda. Slices were 
dewaxed in xylene and rehydrated in alcohol. Antigen retrieval was achieved by microwave 
heating (three times for three min) of the brain slices. Sections were blocked with 10% goat 
serum (Biological Industries, Israel) in PBS and incubated overnight with a mixture of mouse 
anti-TH (1:100, Merck Millipore, Germany, Cat# MAB318 Lot#, RRID: AB_2201528) and 
rabbit anti-Kv7.4 (1:100, AlomoneLabs, Israel, Cat# APC-164 Lot#, RRID: AB_2341042) 
antibodies. Sections were then washed with PBS six times (5 min) and incubated in 
FITC-conjugated AffiniPure goat anti-mouse IgG (Jackson ImmunoResearch, USA, Labs 
  
Cat# 115-095-003, RRID:AB_2338589; 1:200) and Cy3-conjugated AffiniPure goat 
anti-rabbit IgG (Jackson ImmunoResearch, USA; 1:200, Labs Cat# 111-165-003, 
RRID:AB_2338000) for 30 min at 37°C. Sections were then washed six times (5 min) with 
PBS. Subsequently, sections were counterstained with 4,6-diamidino-2-phenylindole (DAPI, 
Sigma, USA) to identify nuclei for 20 min at room temperature, and washed three times with 
PBS (5 min). Finally, slices were mounted with Prolong Gold antifade reagent (Life 
Technologies, USA).  
For experiments shown in Fig. 1A, the brain was fixed in 4% PFA at 4°C for 24 h and 
embedded in 30% sucrose for 24 h. Coronal VTA/SN slices (60 µm) were cut using a 
vibratome (VT1200S; Leica, Germany). Sections were blocked with 10% goat serum 
overnight with a mixture of two primary antibodies: mouse anti-TH (1:100, Merck Millipore, 
Germany) and rabbit anti-Kv7.2 (1:100, Santa Cruz, CA, Cat# sc-7793,  RRID: 
AB_2296585), goat anti-Kv7.3 (1:100, Santa Cruz, CA, Cat# sc-7794 Lot#,  RRID: 
AB_2131714), rabbit anti-Kv7.4 (1:100, AlomoneLabs, Israel), or rabbit anti-Kv7.5 (1:50, 
Santa Cruz, CA, Cat# sc-50416 Lot#, RRID:AB_2131834). Sections were then washed with 
PBS six times (5 min) and incubated in a mixture of two secondary antibodies: 
FITC-conjugated AffiniPure goat anti-mouse IgG (Jackson ImmunoResearch, USA; 1:200) 
and Cy3-conjugated AffiniPure goat anti-rabbit IgG (Jackson ImmunoResearch, USA; 1:200) 
for 30 min at 37°C. Sections incubated with anti-Kv7.3 antibody were incubated in 
Cy5-conjugated AffiniPure donkey anti-goat IgG (Jackson ImmunoResearch, USA, Labs 
Cat# 705-175-147, RRID:AB_2340415; 1:400) and FITC-conjugated AffiniPure donkey 
anti-mouse IgG (Jackson ImmunoResearch, USA, Labs Cat# 715-095-151, 
RRID:AB_2335588; 1:400). 
Images were taken using a Leica TCS SP5 confocal microscope (Leica, Germany) equipped 
with laser lines for DAPI (800 nm, Ti-sapphire coherent pulsed), FITC (Argon 488), cy3 
(HeNe 543) and cy5 (red diode 637 nm). Images were analysed with LAS-AF-Lite software 
(Leica).  
Tissue blocks of the brainstem from human brain were fixed in 4% PFA at 4°C and embedded 
in paraffin. Slices were dewaxed and rehydrated. Antigen retrieval and incubation with 
antibodies were performed by the same protocol used for mouse samples. 
  
Single-cell PCR  
Neurons were aspirated into a patch pipette at the end of electrophysiological recordings. The 
electrode tip was then broken into a PCR tube containing 1 µl of oligo-dT (50 mM) and 1 µl 
of dNTP mixture (10 mM). The mixture was heated to 65°C for 5 min to denature the nucleic 
acids and then placed on ice for 1 min. Single-strand cDNA was synthesized from the cellular 
mRNA by mixing 2 µl of 5× PrimeScript II buffer (50 mM), 0.5 µl of RNase inhibitor (40 
U·µl-1) and 1 µl of PrimeScript II RTase (200 U·µl-1) and then incubating the mixture at 50°C 
for 50 min. Synthesis of single-cell cDNA was performed using a C1000 Touch thermal 
cycler-CFX96 Real-time PCR system (California, USA). First strand synthesis was executed 
at 95°C (5 min) followed by 35 cycles (95°C for 1 min, 56°C for 45 s, 72°C for 50 s) and a 
ILQDOPLQHORQJDWLRQDW&E\DGGLQJWKHVSHFLILF³RXWHU´SULPHUSDLUVWRHDFK3&5WXEH
ILQDO YROXPH  ȝO 7KHQ  ȝO RI WKH SURGXFW RI WKH ILUVW 3&5 ZDV XVHG LQ WKH VHFRQG
amplification round by using the VSHFLILF ³LQQHU´ SULPHU ILQDO YROXPH  ȝO 7KH VHFRQG
amplification round consisted of heating the samples to 95°C for 5 min followed by 30 cycles 
(95°C for 1 min, 54-62°C for 45 s, 72°C for 50 s) and 10 min elongation at 72°C. The 
products of the second round of PCR were analysed in 2.5% agarose gels and stained with 
ethidium bromide. A PrimeScriptTM II 1 st Strand cDNA Synthesis Kit and GoTaq Green 
Master Mix were obtained from Takara-Clontech (Kyoto, Japan) and Promega (Madison, 
USA), respectively. 
7KH³RXWHU´SULPHUVIURPƍWRƍas follows: 
 
GAPDH AAATGGTGAAGGTCGGTGTGA
ACG (sense) 
AGTGATGGCATGGACTGTGGT
CAT (antisense) 
TH ATACAAGCAGGGTGAGCCAA   TACACCGGCTGGTAGGTTTG 
Kv7.2 TCTCCTGCCTTGTGCTTTCT GCATCTGCGTAGGTGTCAAA 
Kv7.4 CCCGGGTGGACCAAATTGT AGCCCTTCAGTCCATGTTGG 
 
 
 
 
  
7KH³LQQHU´SULPHUVIURPƍWRƍas follows: 
GAPDH GCAAATTCAACGGCACAGTC
AAGG 
TCTCGTGGTTCACACCCATCA
CAA 
TH TTCTTGAAGGAACGGACTGGC TCAGCCAACATGGGTACGTG 
Kv7.2 AGGAAGCCGTTCTGTGTGAT GCAGAGGAAGCCAATGTACC 
Kv7.4 ATGGGGCGCGTAGTCAAGGT GGGCTGTGGTAGTCCGAGGTG 
 
qRT-PCR  
Total RNA from the VTA of mice was extracted using a mirVana miRNA Isolation Kit 
,QYLWURJHQ86$DFFRUGLQJWRWKHPDQXIDFWXUHU¶VUHFRPPHQGDWLRQV7KH51$ZDVUHYHUVH
transcribed into cDNA using a PrimeScript RT reagent kit with gDNA Eraser (TAKARA, 
RR047A, Japan). qRT-PCR of Kv7.4 and glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) was performed using an ABI PRISM 7300 Sequence Detection System (Applied 
Biosystems, USA) with a SYBR® Premix Ex Taq II (TliRNaseH Plus) kit (TAKARA, 
RR820A, Japan). The relative amounts of transcripts were normalized to GAPDH; the 
relative RNA expression levels were calculated using the following equation: relative gene 
expression = 2-(ᇞCt sample - ᇞCt control). The following primers were used.  
Kv7.4 ¶- ATGGGGCGCGTAGTCAAGG T-¶VHQVH 
 ¶- GGGCTGTGGTAGTCCGAGGTG -¶DQWLVHQVH 
GAPDH ¶- GGTGAAGGTCGGTGTGAACG -¶VHQVH 
 ¶- CTCGCTCCTGGAAGATGGTG -¶DQWLVHQVH 
 
Drugs  
Retigabine and Y-27632 were from Sigma-Aldrich (China). Fasudil was from the National 
Institute for the Control of Pharmaceutical and Biological Products (Beijing, China). XE991 
dihydrochloride was from Alomone Labs (Jerusalem, Israel). RL-648_81 was synthesized by 
the Department of New Drugs Development, School of Pharmacy, Hebei Medical University. 
All solutions were prepared freshly on the test day. 
 
Statistics  
  
Sample size was determined through power analysis using preliminary data obtained in our 
laboratory with the following assumptions: µĮ¶ of 0.05 (two-tailed) and power of 90%. Data 
are reported as the means ± s.e.m. Statistical analysis of differences between groups was 
FDUULHG RXW E\ 6WXGHQW¶V SDLUHG RU XQSDLUHG W-tests, as appropriate. For data that failed a 
normality test, a paired sample Wilcoxon signed rank test or Mann-Whitney tests was used. 
Multiple groups were compared using one-way ANOVA with Bonferronni¶s correction or by 
Kruskal-Wallis ANOVA with a Mann-Whitney test. P YDOXHV   were accepted as 
si ng ificant. )LVKHU¶VH[DFW test was used to compare population size. Data analysis was carried 
out using OriginPro 9.1 (OriginLab Corp., Northampton, MA). The data and statistical 
analysis comply with the recommendations on experimental design and analysis in 
pharmacology (Curtis, et al.; 2015). 
 
Nomenclature of Targets and Ligands 
Key protein targets and ligands in this article are hyperlinked to corresponding entries in 
http://www.guidetopharmacology.org, the common portal for data from the IUPHAR/BPS 
Guide to PHARMACOLOGY (Southan et al., 2016), and are permanently archived in the 
Concise Guide to PHARMACOLOGY 2015/16 (Alexander et al., 2015). 
 
Results 
Kv7.4 channels are selectively expressed in VTA DA neurons  
It has been shown that among the Kv7/KCNQ isoforms, Kv7.4 is the predominant KCNQ 
gene transcript present in the midbrain VTA (Hansen et al., 2006). We first performed 
detailed analysis of protein and mRNA expression of Kv7/KCNQ isoforms in the midbrain of 
mice, with a special interest in the expression of these Kv7 channels in DA neurons 
(identified by the expression of tyrosine hydrolase, TH). In the immunofluorescence study 
(Fig. 1A, C), Kv7.2-Kv7.5 were found to be differentially expressed in the DA neurons of the 
VTA and the substantia nigra (SN) of the mouse midbrain. Overall, among the four Kv7 
isoforms, Kv7.4 was more selectively expressed in VTA than SN DA neurons. Thus, while 
66% of TH-positive (DA) neurons in the VTA expressed Kv7.4, only 27% of these neurons in 
the SN expressed this channel (P < 0.001)LVKHU¶VH[DFWWHVW$PRQJthe other Kv7 subunits, 
  
only Kv7.5 exhibited a slightly higher incidence of expression in the VTA compared to the 
SN (33% vs. 22% neurons, respectively, P > 0.05; Fig. 1C), yet the proportion of 
Kv7.5-positive neurons in the VTA was still significantly lower compared to the proportion 
of Kv7.4-positive neurons (33% vs. 66% of neurons respectively, P < 0.001; Fig. 1C). 
Interestingly, Kv7.2 significantly more frequently expressed in SN neurons (62%) compared 
to VTA neurons (62% vs 45%; P < 0.05; Fig. 1C). Kv7.3 and Kv7.5 were expressed in much 
smaller proportions of VTA DA neurons (Fig. 1C). 
Similarly, in a single-cell PCR study (Fig. 1B, C), Kv7.4 was also found to be more 
selectively expressed in VTA DA neurons (63% vs 19% in SN; P < 0.001), whereas the 
expression of Kv7.2 was more abundant in SN DA neurons (55% vs 34% in VTA, P = 0.12; 
Fig. 1C). Kv7.4 was absent in VTA DA neurons of the Kv7.4 knockout mice (Kv7.4-/-; Fig. 
1D). Kv7.4 expression was also found in human VTA DA neurons (Fig. 1E). Taken together, 
the results presented in Fig. 1 demonstrate that, while several Kv7 isoforms are expressed in 
VTA DA neurons, Kv7.4 is the predominant subunit. 
 
Fasudil selectively activates Kv7.4 currents in VTA DA neurons  
We next aimed to selectively modulate Kv7.4 channels to regulate the excitability of VTA 
DA neurons. Our first goal was to identify a Kv7.4-selective modulator. In a separate 
investigation of the effects of a Rho-associated protein kinase (Uehata et al., 1997) inhibitor 
fasudil (1-[5-isoquinolinesulfonyl]-homopiperazine, HA-1077, AT-877) in the cardiovascular 
system, we discovered that fasudil is also a selective opener of Kv7.4 channels (Zhang et al., 
2016). In CHO cells that exogenously express Kv7.4, fasudil enhanced Kv7.4 currents in a 
concentration-dependent manner but did not affect Kv7.2 currents (Fig. 2A1-A3). RTG, a 
prototypic non-selective opener of Kv7 channels (Tatulian et al., 2001) enhanced both Kv7.4 
and Kv7.2 currents, which were inhibited by the Kv7 blocker XE991 (Fig. 2A1-A2). 
Importantly, fasudil did not activate heterologously expressed Kv7.2/Kv7.3 multimeric 
channels (sFig. 3), which are the major correlates of the M-type current in the CNS (Wang et 
al., 1998). Fasudil did not affect Kv7.1 and Kv7.3 channels but did activate Kv7.4/Kv7.5 
multimers (Zhang et al., 2016). Thus, we concluded that fasudil is a selective activator of 
Kv7.4-containing homo- and hereromeric Kv7 channels. 
  
We then tested the effect of fasudil on K+ currents in VTA neurons. We recorded Kv7/M-like 
currents from VTA/SN slices of adult mice (6-8 weeks). The currents were recorded using 
the protocol shown in the right panel of Fig. 2B1 as the characteristic slow deactivating tail 
current at -50 mV, which is defined as the µ0 FXUUHQW¶ DQG LV PRVWO\ FRQGXFWHG E\ .Y
channels (Koyama and Appel, 2006). Accordingly, 45.6 ± 6.0% of the deactivating current 
wDVLQKLELWHGE\;(ȝ0)LJB1). In these experiments, we used well-characterized 
hallmarks to select DA neurons (sFig. 1; see Methods for details). As it has been reported and 
consistent with our results shown in Fig. 1, the majority (~70%) of VTA neurons are DA 
neurons, with a small population of GABAergic neurons and glutamatergic neurons 
(Nair-Roberts et al., 2008). Due to these considerations, the selection criteria, and the 
subsequent confirmation by post-recording single-cell RT-PCR (see below), most of the 
recorded neurons were indeed DA neurons.   
Fasudil induced a prominent increase in M-like currents in VTA DA neurons (Fig. 2B1, 2C), 
with potency similar to that recorded in CHO cells overexpressing exogenous Kv7.4 (Fig. 
2B3). Deletion of Kv7.4 (Kv7.4-/- mice) greatly reduced the basal Kv7/M-like K+ currents and 
completely abolished the fasudil-induced Kv7/M-like K+ currents in VTA DA neurons (Fig. 
2B2, B3, 2C). These results strongly suggest that i) fasudil selectively activates Kv7.4 and ii) 
Kv7.4 is the functionally dominant Kv7 channel subunit in VTA DA neurons. The residual 
small basal currents and the RTG-activated currents in the Kv7.4-/- mice (Fig. 2C) could arise 
from other Kv7 subunits (Fig. 1A-C). We also tested the effects of fasudil on Kv7/M-like 
currents of SN DA neurons. Unlike in VTA DA neurons, fasudil did not induce significant 
activation of Kv7/M currents in SN neurons (from 94.1 ± 0.7 pA to 94.4 ± 0.2 pA by 100 PM 
fasudil treatment, n = 22, P > 0.05, paired t test).  
 
Kv7.4 activity controls the excitability of VTA DA neurons 
Next, we tested the influence of Kv7.4 on the excitability of VTA DA neurons. Excitability 
was recorded using a loose cell-attached patch method (Williams and Wozny, 2011; Burlet et 
al., 2002) from brain slices of WT and Kv7.4-/- mice. We recorded from VTA neurons 
located primarily in the lateral part of the VTA, as projections from this portion of VTA DA 
neurons are more likely to be involved in depression-like behaviour (Barbara et al., 2016). 
  
The placement of recording electrodes and the positions of recorded neurons are shown in the 
schematic of Fig. 3A2 (top). We recorded the spontaneous firing of VTA neurons with action 
potential wave form characteristics of DA neurons (sFig. 1, Methods) (Fig. 3A1, right panel). 
)DVXGLO  ȝ0 VLJQLILFDQWO\ UHGXFHG WKH DYHUDJH ILULQJ IUHTXHQF\ RI 97$ QHXURQV )LJ
3A1, D). Post-recording single-cell PCR analysis confirmed that the inhibitory effect of 
fasudil resulted from activation of Kv7.4, as fasudil only inhibited firing in VTA DA neurons 
that expressed Kv7.4 but did not inhibit firing in Kv7.4-negative neurons (Fig. 3A2). The DA 
phenotype of these neurons was additionally confirmed by TH expression (Fig. 3A2).  
Fasudil did not affect the firing frequency in VTA DA neurons of Kv7.4-/- mice (Fig. 3B, 3D). 
Consistent with the limited expression of Kv7.4 in the SN, the firing of DA SN neurons was 
not significantly affected by fasudil (Fig. 3C, 3D). On the other hand, the firing of both VTA 
and SN neurons was inhibited by non-selective Kv7 opener, RTG and by a selective Kv7.2 
opener RL-648-81 (10 PM) (Kumar et al., 2016) (Fig 3A-3D); the effect of RTG was 
persistent in Kv7.4-/- mice (Fig 3B, 3D). These data support our finding that Kv7.2 is present 
in both VTA and SN neurons (Fig. 1). In further evidence supporting a role of Kv7.4 in 
controlling DA neuron excitability, we found that the absence of Kv7.4 (Kv7.4-/-) renders 
VTA DA neurons with a higher spontaneous firing frequency (Fig. 3E, 1.8 ± 0.2 Hz vs 1.1 ± 
0.1 Hz, for Kv7.4-/- and WT mice respectively, P < 0.05, one-way ANOVA). Furthermore, 
DA neurons in the SN of WT mice, which have limited expression of Kv7.4, also had a 
higher firing frequency compared to VTA DA neurons from WT mice (Fig. 3E, 1.10 ± 0.1 Hz 
vs. 1.96 ± 0.27 Hz, for the VTA and SN respectively, P < 0.05, one-way ANOVA). On the 
other hand, no difference in firing frequency between SN neurons from WT mice and Kv7.4-/- 
mice was found (Fig. 3E).  
We further tested the effects of Kv7 channel modulation on the excitability of VTA DA 
neurons using current-clamped whole-cell recordings from VTA slices. In these experiments, 
the following parameters were recorded: i) the resting membrane potential (RMP) (sFig. 4A), 
ii) the induced action potential firing frequency (sFig. 4B, C), and iii) the spontaneous firing 
rates (sFig. 4D). Comparison of the above parameters between WT and Kv7.4-/- mice clearly 
indicated that Kv7.4 constitutively modulates the excitability of VTA DA neurons. 
Finally, the contribution of Kv7.4 in the regulation of VTA DA neuronal excitability was also 
  
assessed in an in vivo setting. The spontaneous firing of VTA DA neurons was recorded in 
vivo using an extracellular single unit recording method (Fig. 3F). In this recording paradigm, 
two patterns of firing (Fig. 3F, expanded traces) were often recorded from the same neurons, 
the tonic firing (Fig. 3F1) and burst firing (Fig. 3F2; see Method for detail), and both total 
firing frequency and the burst firing properties were analysed (Krishnan et al., 2007). In WT 
mice, intraperitoneally injected fasudil (i.p.; 20 mg·kg-1) reduced the total firing frequency 
(Fig. 3G1, G2) and the percentage of spikes in bursts (Fig. 3G3) and increased the ISI (Fig. 
3G1). In stark contrast, in Kv7.4-/- mice, neither the total firing frequency nor the percentage 
of spikes in bursts was affected by fasudil treatment (Fig. 3G2, G3). 
 
The role of Kv7.4 in the development of a depression-like phenotype in a social defeat 
model of depression  
Increased activity of VTA DA neurons is directly related to depression-like behaviours in the 
social defeat model of depression (Cao et al., 2010; Chaudhury et al., 2013; Friedman et al., 
2014.; Krishnan et al., 2007). Because Kv7.4 plays a significant role in controlling the 
excitability of VTA DA neurons, we investigated whether altered Kv7.4 channel activity is a 
causal factor for the increased excitability of VTA DA neurons observed in the social-defeat 
mice model. For this, we first established a model of social defeat (Fig. 4A, sFig. 2; see 
Methods for detail). The depression-like state of mice was verified by reduced sucrose 
preference (Fig. 4B) and reduced social interaction time when DQµDJJUHVVRU¶&'PRXVHZDV
present (Fig. 4C). Mice that exhibited reduction in both parameters were defined as 
µVXVFHSWLEOH PLFH¶ 686 Mice with both parameter unaltered were identified as 
µXQVXVFHSWLEOHPLFH¶81686 (Chaudhury et al., 2013; Krishnan et al., 2007).  
Consistent with the previous reports, the firing activity of VTA DA neurons, recorded using 
the in vivo single unit recording method, was higher in SUS mice than in  control and 
UNSUS mice (3.79 ± 0.17 Hz, n = 98 in SUS mice vs. 2.18 ± 0.25 Hz, n = 27 in control mice, 
or 2.34 ± 0.32 Hz, n = 10 in UNSUS mice) (Fig. 4D). Importantly, burst firing also increased 
in SUS mice compared to control and UNSUS mice (36.35 ± 3.02%, n = 43 in SUS mice vs. 
22.35 ± 2.54%, n = 18 in control mice, or 21.35 ± 4.25%, n = 10 in UNSUS mice) (Fig. 4E); 
this was reported to be an important determinant of depression-like behaviour in mice 
  
(Chaudhury et al., 2013; Krishnan et al., 2007).  
We then recorded Kv7/M currents of VTA DA neurons from SUS and UNSUS mice. As 
shown in Fig. 4F, Kv7/M currents were reduced in SUS mice compared with control and 
UNSUS mice (Fig. 4). To test if the reduced Kv7/M currents were due to  down-regulation 
of Kv7.4 expression, we first measured Kv7.4 mRNA levels using qPCR. The results shown 
in Fig. 4G demonstrated that indeed the mRNA levels of Kv7.4 were indeed lower in the 
VTA of SUS mice compared with control and UNSUS mice. We also performed a correlation 
analysis and found that the firing frequency of VTA DA neurons was strongly negatively 
correlated with the expression level of Kv7.4 mRNA (R2 = 0.75), regardless of the 
SUS/UNSUS phenotype (Fig. 4H). We also measured the levels of Kv7.4 protein in the VTA 
and found that Kv7.4 protein abundance in the VTA of SUS mice was similarly reduced 
compared to the levels in control and (to a lesser extend) UNSUS mice (Fig. 4I), in good 
agreement with the RT-PCR data.  
Fasudil reduces VTA DA neuronal excitability and reverses depression-like behaviour  
The results thus far allowed us to hypothesize that fasudil, by activating Kv7.4 in VTA DA 
neurons, should be able to ameliorate the increased excitability of VTA DA neurons and the 
related depression-like behaviour in a social defeat mouse model of depression. We used 
several approaches to test this hypothesis. First, we used the cell-attached recordings of VTA 
DA neuronal firing of control, SUS and UNSUS mice. Indeed, fasudil reduced the firing rate 
of VTA DA neurons in SUS mice by 31.6 ± 12.2% (from a basal value of 2.53 ± 0.39 Hz, n = 
12; Fig. 5A1, 5A2), although it was less efficacious than in control mice (42.2 ± 13.5% 
reduction from a basal value of 1.46 ± 0.25 Hz, n = 8; Fig. 5A1, 5A2). These results are 
consistent with reduced (but not abolished) Kv7.4 channel expression and reduced M current 
amplitudes in the VTA DA neurons of SUS mice.  
In further experiments, using in vivo single unit recordings we found that the total firing 
activity of DA neurons in the VTA of WT mice was decreased and that ISI increased 
significantly following intraperitoneal injection of fasudil (20 mg·kg-1) or RTG (10 mg·kg-1), 
but not vehicle (0.9% saline, 0.15 ml; Fig. 5B and 5C). Similarly, burst firing was also 
decreased after treatment with fasudil and RTG (Fig. 5D, E). However, in Kv7.4-/- mice, 
fasudil failed to affect the firing of VTA DA neurons whereas RTG remained to be effective 
  
albeit with a reduced efficacy (Fig. 5C).  
Most importantly, the social defeat-induced avoidance behaviour of WT SUS mice was 
reversed by acute administration (i.p.) of fasudil and RTG. Specifically, in vehicle-treated 
SUS mice, introduction of the unfamiliar CD1 mouse into the interaction test box (sFig. 2B; 
Methods) induced an avoidance response from the tested mice. Thus, the time that the tested 
mice spent in the interaction zone was reduced (Fig 5F), indicating depression-like behaviour 
induced by social defeat. However, when WT SUS mice were injected with either RTG or 
fasudil, the time that the tested mice spent in the interaction zone in the presence of the 
µDJJUHVVRU¶&' mouse was not significantly different from the control period (without the 
µDJJUHVVRU¶7KLVLQGLFDWHVWKDW.YFKDQQHORSHQHUVLQGHHGDEROLVKHGWKHDYRLGDQFHUHDFWLRQ
to the introduction of the unfamiliar CD1 mice, indicating a reversal of depression-like social 
interaction deficit. It should be noted that when a CD1 mouse was absent, the time spent in 
the interaction zone for SUS mice from vehicle, fasudil or RTG treatment groups (Fig. 5F) 
was not significantly different (59.15 ± 5.60 s, n = 13 in vehicle group; 48.54 ± 4.00 s, n = 13 
in fasudil group; 48.43 ± 5.75 s, n = 7 in RTG group; P = 0.41 vehicle vs. fasudil, P = 0.61 
vehicle vs. RTG and P = 0.99 fasudil vs. RTG; One-way ANOVA). In Kv7.4-/- mice however, 
fasudil failed to affect the behavioural response of SUS mice to the presence of the CD1 
µDJJUHVVRU¶)LJ5G); RTG, however, was still effective (Fig. 5G) but the effect was highly 
variable. Notably, under RTG treatment, WT, as well as Kv7.4-/- mice became less active e.g., 
their mobility in the open field test was significantly reduced (sFig. 5B, C); this was 
consistent with the previously reported sedative effect of RTG (Hayashi et al., 2014). Fasudil 
on the other hand, did not affect the general activity of the mice of either genotype (sFig. 5B, 
C). These data suggest that RTG, but not fasudil, exerts a central, Kv7.4-independent sedative 
effect.  
To provide direct evidence that fasudil, when administered systemically through 
intraperitoneal injection, reversed the fault in social interaction of the social defeat mice 
through action on VTA DA neurons, fasudil was also infused directly onto the VTA through 
a cannula implanted to delver mounted on the top of the VTA (Fig. 6E, see Methods for 
details). Different concentrations of fasudil (and RTG) were first tested to select a 
concentration of the drug to obtain an effect on VTA DA neuronal firing activity comparable 
  
to that recorded after systemic administration. Ultimately, 200 µM was chosen to further test 
the effects of localized drug delivery on social interaction behaviour. At 200 PM both fasudil 
and RTG induced significant inhibition on VTA neuron firing activity (Fig. 6A-C). Social 
interaction was tested at two time points after fasudil was administered, 5 min and 40 min; a 
time-matched (5 min) vehicle control was also tested (Fig. 6D). At both time points, local 
VTA infusion of IDVXGLORU57*DEROLVKHGµDJJUHVVRU¶DYRLGDQFHDQGQRUPDOL]HGWKHWLPHD
mouse spent in the interaction zone (Fig. 6F) and in the corner zone (Fig. 6G) in the presence 
of a &' µDJJUHVVRU¶ 7KXV VLPLODU WR V\VWHPLF DGPLQLVWUDWLRQ GLUHFW ORFDO LQMHFWLRQ RI
fasudil into the VTA also reversed the depression-like social interaction behaviour. 
 
Discussion 
Here, we demonstrate that 1) Kv7.4 is selectively expressed in VTA DA neurons and 
represents a major Kv7/M channel subunit in in these cells; 2) Kv7.4 plays a key role in the 
regulation of VTA DA neuronal excitability; 3) down-regulation of Kv7.4 strongly 
contributes to the increased excitability of the VTA DA neurons and, thus, may trigger the 
development of a depression-like state in mice. Finally, 4) fasudil is a selective Kv7.4 opener, 
and its targeted modulation of Kv7.4 significantly improves depression-like behaviour in the 
social defeat mouse model of depression. Since VTA DA neuronal excitability is critical in 
the development of depressive state (Chaudhury et al., 2013; Tye et al., 2013), Kv7.4 
represents a promising target for developing new antidepressants. In this regard, our finding 
of selective activation of Kv7.4 and subsequent Kv7.4-dependent reversal of a depression 
states by fasudil is particularly exciting. Kv7.4 has a much more restricted expression in the 
CNS compared to Kv7.2 and Kv7.3 (Hansen et al., 2006; Hansen et al., 2008). This reduces 
the risk of on-target side effects of a selective Kv7.4-based therapy compared to 
broad-spectrum M channel targeting with currently available drugs such as RTG. Consistent 
with this hypothesis, in our behavioural experiments, fasudil did not produce a sedative effect, 
while RTG was clearly sedative (sFig. 5). The fact that fasudil is already a clinically 
approved drug used for the treatment of cerebral vascular spasm (Uehata et al., 1997), makes 
these findings even more relevant. Importantly, the anti-excitatory effects of fasudil in the 
VTA are likely to be independent of its Rho kinase inhibitior activity, since an another 
  
unrelated Rho kinase inhibitor, Y-27632, did not affect the excitability of VTA DA neurons 
recorded either both in vitro and in vivo (sFig. 6). 
The argument that K+ channel openers can be used to treat depression is based on the 
rationale that increased VTA DA neuronal excitability is linked to the development of 
depression, and thus, K+ channel openers may help to reverse the over-excitable state of the 
VTA. The VTA activation theory is applicable to the social defeat depression model (Cao et 
al., 2010; Chaudhury et al., 2013; Friedman et al., 2014; Krishnan et al., 2007). In this model 
of depression, it is believed that increased phasic firing of VTA DA neurons via increased 
release of BDNF in the nucleus accumbens (NAc) confers individual susceptibility to 
stressful stimulation (Chaudhury et al., 2013; Krishnan et al., 2007). Elevated K+ channel 
activity could counteract the increased VTA DA activity and alleviate depressive behaviour 
(Friedman et al., 2014; Krishnan et al., 2007; Friedman et al., 2016). Thus, the VTA DA 
activation theory implicates the increased burst firing rates of VTA-NAc DA neurons as a 
crucial mediator of social-stress-induced depressive behaviour (Walsh and Han, 2011). Our 
results conform well to this theory: the targeted activation of Kv7.4 K+ channels reduced the 
increased excitability of VTA DA neurons and at the same time improved the depression-like 
behaviour of socially defeated mice. Importantly, the Kv7.4-selective opener produced much 
fewer side-effects compared to the broad-spectrum Kv7 channel opener RTG. 
The elevated neuronal excitability in VTA DA neurons of Kv7.4-/- mice might suggest a 
phenotype of depression. However, this was not the case; no depressive behaviour was 
observed in Kv7.4-/- mice, and Kv7.4-/- mice developed depression behaviour after being 
subjected to the stressful stimulation. This indicates that the elevated VTA neuronal 
excitability is essential but not sufficient for inducing the depression behaviour, and therefore, 
additional factors, such as corticotrophin release factor (Walsh and Han, 2011), may be 
necessary. Thus, a stress-context is a precondition for the involvement of VTA DA neurons in 
the development of depressive behaviour (Chaudhury et al., 2013). 
The role of VTA DA neuronal activity in the development of depression raises another 
question: could the reduced expression/activity of K+ channels (including that of Kv7 induced, 
for example, by stress) (Zhou et al., 2016) be a causative factor in the altered firing of VTA 
DA neurons and the depression-like behaviours related to such altered firing? The results 
  
found thus far suggest that this may be the case. Earlier studies showed that elevated 
expression/activity of K+ channels (including Kv7.3/KCNQ3) could be responsible for the 
lack of susceptibility in a subpopulation of mice that do not develop depression-like 
behaviour in the social defeat paradigm (Friedman et al., 2014; Krishnan et al., 2007; 
Friedman et al., 2016). In the current study, we found that the mRNA and protein expression 
of Kv7.4 were lowered in  SUS mice compared with UNSUS mice. Thus, our study suggests 
that the down-regulation of Kv7.4 abundance is possibly among the causative factors of  
changes in the excitability of VTA DA neurons, which determines depressive behaviours 
(Chaudhury et al., 2013; Tye et al., 2013). 
It has to be noted that our findings were obtained with the use of a single depression model. 
Different models of depression may involve different neuronal mechanisms, including the 
activity of VTA DA neurons (e.g. reduced activity of VTA DA neuron in the mice depression 
model of the unpredictable chronic mild stress, Chaudhury et al., 2013; Tye et al., 2013). This 
may underlie the complexity of major depression demonstrated in clinical patients and their 
heterogeneous responses to antidepressants. Therefore, future studies are necessary to test if 
the mechanisms discovered here contribute to development of depression in other animal 
models and in human patients. Nevertheless, targeting a causal molecular mechanism of 
depression (such as a loss of functional activity of Kv7.4), rather than fighting symptoms of 
the disease might provide a better strategy for development of new antidepressants. 
In summary, in this study, we provide strong evidence that Kv7.4 is a key modulator of VTA 
DA neuronal excitability participating in the development of depressive behaviour. 
Furthermore, selective targeting of Kv7.4 in VTA DA neurons with drugs such as fasudil 
presents a potential new strategy for the treatment of major depressive disorder.. 
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Fig. 1  
The expression of Kv7 channels in the midbrain. (A) Representative immunofluorescence 
images of the co-expression of Kv7 subunits (Kv7.2, Kv7.3, Kv7.4 and Kv7.5) and tyrosine 
hydroxylase (TH) in themesencephalon of the mice. The ventral tegmental area (VTA) and 
substantia nigra (SN) are highlighted by the red and yellow dotted circles, respectively, and a 
zoomed-in area of the VTA is shown by the dotted square and the white arrows. A schematic 
of the VTA (red) and SN (yellow) areas in the map of a midbrain coronal section is also 
  
shown in the inset on the right. (B) Reverse-transcription (RT) PCR analysis of single 
neurons from VTA and SN brain slices. The lane numbers correspond to individual neurons; 
³QR´GHQRWHV WKHQHJDWLYH FRQWURO LQZKLFKQR WHPSODWH QHXURQDO O\VDWHZDV DGGHG LQ WKH
RT-PCR reaction. The expected sizes of the DNA products for tyrosine hydroxylase (TH) and 
Kv7s are shown. (C) Proportions of dopamine (DA) neurons (TH-positive) expressing 
individual Kv7 subunits, analysed for protein (immunofluorescence) and mRNA (single cell 
PCR) levels. (D) Immunofluroscence identification of Kv7.4 (red) and TH (green) expression 
in the VTA of wild-type and Kv7.4 knockout (Kv7.4-/-) mice. (E) Kv7.4 (red) and TH (green) 
in a VTA slice from a human brain 
 . 
 
 
Fig. 2  
Fasudil selectively activates Kv7.4 currents in CHO cells and VTA DA neurons. Whole-cell 
patch clamp recordings from CHO cells and DA neurons in brain slices. (A1) Fasudil 
 . 
enhanced the currents of Kv7.4 channels stably expressed in CHO cells. The time course 
shows on the left is the time lapsed deactivating tail current amplitudes recorded at -60 mV 
from a depolarizing steps to -10 mV in 20 s intervals. Example current traces in the absence 
or SUHVHQFHRIȝ0ȝ0RUȝ0IDVXGLOare shown on the right with the voltage pulse 
protocol shown in the inset above the traces. (A2) )DVXGLOȝ0ȝ0RUȝ0GLGQRW
affect Kv7.2 currents, while RTG (10 µM) induced a 3-fold augmentation. (A3) 
Concentration-response curve for the effect of fasudil on Kv7.4 currents fitted with a logistic 
function; EC50 = 14.2 ± 0.6 µM. Fasudil had no detectable effect on the Kv7.2 currents. (B) 
Kv7/M currents recorded from VTA DA neurons from wild-type and Kv7.4-/- mice. (B1) 
VKRZV WKH HIIHFWV RI IDVXGLO  ȝ0  ȝ0 RU  ȝ0 RQ WKH ;(-sensitive (3 PM) 
deactivating tail currents measured at -50 mV (left). The protocol used to induce Kv7/M 
currents and the corresponding current traces are shown in the right panel. (B3) The 
concentration-response relationships of the effect of fasudil on Kv7/M currents in DA 
neurons fitted with the logistic function; EC50 = 11.6 ± 0.8 ȝ0(C) The summarized effects 
of fasudil, RTG and XE991 on Kv7/M current amplitude in VTA DA neurons from wild type 
and Kv7.4-/- mice * P < 0.05, paired sample Wilcoxon signed ranks test for fasudil, paired 
t-test for XE991 and RTG; n is the number of cells and N is the number of animals. 
 This article is protected by copyright. All rights reserved. 
 
 
Fig. 3 
Fasudil decreases spontaneous firing of VTA DA neurons. (A-C) Cell-attached recording of 
spontaneous firing of DA neurons from VTA and SN areas. (A1) Effect of fasudil (10 ȝ0
DQG57*ȝ0RQ the spontaneous firing frequency of VTA DA neurons from wild type 
 This article is protected by copyright. All rights reserved. 
mice. Example recordings and action potential waveforms are shown on the right. (A2) Left: 
Post-recording single-cell PCR shows the presence of Kv7.4 in TH-positive neurons. The 
inset on the top shows a map of a coronal midbrain slice indicating the location of neurons 
that were recorded and subsequently analysed with RT-PCR indicated (red dots). Right panel 
summarizes the effects of fasudil on the firing frequency of Kv7.4-positive and 
Kv7.4-negative TH-expressing neurons. (B) Effect of fasudil and RTG on spontaneous firing 
of VTA DA neurons from a Kv7.4-/- mouse. (C) Effect of fasudil and RTG on the spontaneous 
firing of SN DA neurons from a wild-type mouse. (D) Summary of the effects of fasudil, 
RTG and a Kv7.2 selective activator RL-648 81 on spontaneous firing frequency of VTA and 
SN DA neurons. * P < 0.05, N.S., not significant, paired t-test. (E) Summary of the 
spontaneous firing frequencies of VTA and SN DA neurons from wild type and Kv7.4-/- mice. 
(F) In vivo single unit recording of spontaneously firing of VTA DA neurons. Tonic (F1) and 
burst (F2) firing DA neurons are exemplified. (G1) The time course of the firing frequency 
and the ISI of DA neurons following intraperitoneal injection (i.p.) of fasudil (20 mg·kg-1) or 
vehicle (0.9% saline). The average firing frequency within 1 min bins is plotted against time. 
(G2) Summary of the effects of fasudil on the firing frequency recorded in experiments 
similar to those shown in G1. * P < 0.05, one-way ANOVA. (G3) Summary of the effects of 
fasudil on the incidence of burst firing (percentage of spikes in bursts). * P < 0.05, one-way 
ANOVA. n is the number of cells and N is the number of animals. 
  
 
 
Fig. 4  
The role of Kv7.4 on the increased activity of VTA DA neurons in the social defeat model of 
depression. (A) Timeline of the chronic social defeat model. (B) The sucrose preference test. 
SUS-susceptible mice, UNSUS-unsusceptible mice (for detail see Methods). * P < 0.05, 
one-way ANOVA. (C) Social interaction test. The time that the test mice spent in the 
  
LQWHUDFWLRQ]RQHLQWKHDEVHQFHµ1R&'¶RUSUHVHQFHµ&'¶RIDQXQIDPLOLDU&'PRXVH
* P < 0.05, paired t-test. (D) Summary of VTA DA neuronal firing frequenciesof the in vivo 
single-unit recordings from control, SUS and UNSUS mice. (E) Percentage of spikes in 
bursts during the spontaneous firing of VTA DA neurons from control, SUS and UNSUS 
mice. * P < 0.05, one-way ANOVA. (F) Kv7.4/M current amplitudes of VTA DA neurons 
from control, SUS and UNSUS mice, recorded using whole-cell patch clamp recording. N.S., 
not significant, Kruskal-Wallis ANOVA and Mann-Whitney test. (G) Kv7.4 mRNA 
expression measured with Q-PCR. * P < 0.05, one-way ANOVA. (H) Correlation analysis of 
Kv7.4 mRNA levels and the firing frequency of the VTA DA neurons (P = 0.0000129, y = 
-0.0902x + 1.1714, R2 = 0.7541; linear correlation analysis). The firing of VTA DA neurons 
was recorded using single unit recording. Each point in the chart represented a result from a 
separate mouse. (I) Kv7.4 protein levels measured using western blot. * P < 0.05, one-way 
ANOVA; n is the number of cells and N is the number of animals. 
  
 
 
Fig. 5.  
Fasudil reverses the depression-like behaviour in the mice developing social defeat through 
the activation of Kv7.4. (A1) Effect of fasudil on the spontaneous firing rate of VTA DA 
  
neurons from control and SUS mice from cell-attached recording of DA neurons in VTA 
slices. * P < 0.05, paired t-test. (A2) Normalized firing frequency based on the data shown in 
A1. * P < 0.05, N.S., not significant, one sample Wilcoxon signed ranks test. (B) Effect of 
fasudil (20 mg·kg-1, i.p.), RTG (10 mg·kg-1, i.p.) or vehicle (0.9% saline) on the firing 
frequency and the ISI of VTA DA neurons recorded using in vivo single unit recording. The 
average firing frequency within 1 min bins is plotted against time. (C) Summary of the effect 
of fasudil and RTG on the firing frequency of VTA DA neurons from WT and Kv7.4-/- mice. 
(D) Effect of fasudil and RTG on the incidence of burst firing. * P < 0.05, one-way ANOVA. 
(E) Effect of fasudil and RTG on the number of spikes in a burst. * P < 0.05; one-way 
ANOVA. (F) Effect of vehicle, fasudil and RTG on the social interaction time of social defeat 
WT mice. N.S., not significant, paired t-test. (G) Effect of vehicle, fasudil and RTG on the 
social interaction time of social defeat Kv7.4-/- mice. N.S., not significant, paired t-test. n is 
the number of cells and N is the number of animals. 
  
  
 
 
Fig. 6.  
Microinfusion of fasudil into the VTA decreases the spontaneous firing of VTA DA neurons 
and reverses depression-like behaviour. (A) The time courses of the firing frequency of DA 
neurons following local injection of fasudil (200 ȝM; top) or RTG (200 ȝM; bottom) into the 
VTA of mice. (B) Summary of the  effects of fasudil and RTG on the firing frequency 
recorded in experiments similar to those shown in A. (C) Summary of the effects of fasudil 
and RTG on the incidence of burst firing (percentage of spikes in bursts). (D) Timeline for 
  
the establishment of the social defeat model, the interaction test and the microinfusion of 
drugs. (E) Schematic depiction of cannula placement for direct microinjections of drugs into 
the VTA. (F and G) Summary of the effect of fasudil on social interaction: the time spent in 
the interaction zone (F) and in the corner zone (G) Tests were performed 5 and 40 min after 
the direct VTA infusion of fasudil (0.08 Pg, 200 ȝM, 0.4 Pl). N.S, not significant, paired 
t-test. N is the number of animals tested. 
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